Clinical Trial Update: Shockwave Coronary Lithoplasty® Study (Disrupt CAD II) [NA]

View source ↗

Summary

Clinical trial update for the Shockwave Coronary Lithoplasty Disrupt CAD II study has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Shockwave Coronary Lithoplasty

Snippet

Sponsor: Shockwave Medical, Inc. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2019-11-08